Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Effect of apoptotic cell recognition on macrophage polarization and mycobacterial persistence.

de Oliveira Fulco T, Andrade PR, de Mattos Barbosa MG, Pinto TG, Ferreira PF, Ferreira H, da Costa Nery JA, Real SC, Borges VM, Moraes MO, Sarno EN, Sampaio EP, Pinheiro RO.

Infect Immun. 2014 Sep;82(9):3968-78. doi: 10.1128/IAI.02194-14.

2.

Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.

Moura DF, Teles RM, Ribeiro-Carvalho MM, Teles RB, Santos IM, Ferreira H, Fulco TO, Nery JA, Sampaio EP, Sarno EN.

Br J Dermatol. 2007 Aug;157(2):273-83.

PMID:
17553031
3.

Induction of apoptosis in monocytes by Mycobacterium leprae in vitro: a possible role for tumour necrosis factor-alpha.

Hernandez MO, Neves I, Sales JS, Carvalho DS, Sarno EN, Sampaio EP.

Immunology. 2003 May;109(1):156-64.

4.
5.

Changes in cellular response to mycobacterial antigens and cytokine production patterns in leprosy patients during multiple drug therapy.

Trao VT, Huong PL, Thuan AT, Anh DD, Trach DD, Rook GA, Wright EP.

Immunology. 1998 Jun;94(2):197-206.

6.

Interaction of Mycobacterium leprae with the HaCaT human keratinocyte cell line: new frontiers in the cellular immunology of leprosy.

Lyrio EC, Campos-Souza IC, Corrêa LC, Lechuga GC, Verícimo M, Castro HC, Bourguignon SC, Côrte-Real S, Ratcliffe N, Declercq W, Santos DO.

Exp Dermatol. 2015 Jul;24(7):536-42. doi: 10.1111/exd.12714.

PMID:
25828729
7.

M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.

Shankar P, Agis F, Wallach D, Flageul B, Cottenot F, Augier J, Bach MA.

J Immunol. 1986 Jun 1;136(11):4255-63.

PMID:
2422278
8.

Susceptibility to Mycobacterium leprae of ALY (alymphoplasia) mice and IFN-gamma induction in the culture supernatant of spleen cells.

Yogi Y, Endoh M, Banba T, Okamura H, Nomaguchi H.

Int J Lepr Other Mycobact Dis. 1998 Dec;66(4):464-74.

PMID:
10347567
10.

CD163 favors Mycobacterium leprae survival and persistence by promoting anti-inflammatory pathways in lepromatous macrophages.

Moura DF, de Mattos KA, Amadeu TP, Andrade PR, Sales JS, Schmitz V, Nery JA, Pinheiro RO, Sarno EN.

Eur J Immunol. 2012 Nov;42(11):2925-36. doi: 10.1002/eji.201142198.

11.

TLR6-driven lipid droplets in Mycobacterium leprae-infected Schwann cells: immunoinflammatory platforms associated with bacterial persistence.

Mattos KA, Oliveira VG, D'Avila H, Rodrigues LS, Pinheiro RO, Sarno EN, Pessolani MC, Bozza PT.

J Immunol. 2011 Sep 1;187(5):2548-58. doi: 10.4049/jimmunol.1101344.

12.

HLA and leprosy in the pre and postgenomic eras.

Geluk A, Ottenhoff TH.

Hum Immunol. 2006 Jun;67(6):439-45. Review.

PMID:
16728267
13.

Lysis of autologous macrophages pulsed with hsp10 from Mycobacterium leprae is associated to the absence of bacilli in leprosy.

de la Barrera S, Fink S, Finiasz M, Alemán M, Helena Fariña M, Pizzariello G, del Carmen Sasiain M.

Immunol Lett. 2001 Feb 1;76(1):55-62.

PMID:
11222914
14.
15.

IFN-gamma, IL-6 and IL-4 modulate M. leprae- or PPD-specific cytotoxic T cells in leprosy patients.

Fink S, de la Barrera S, Minnucci F, Valdez R, Baliña LM, Sasiain MC.

Scand J Immunol. 1993 Dec;38(6):551-8.

PMID:
8256114
16.

Increase in TGF-β secreting CD4⁺CD25⁺ FOXP3⁺ T regulatory cells in anergic lepromatous leprosy patients.

Saini C, Ramesh V, Nath I.

PLoS Negl Trop Dis. 2014 Jan 16;8(1):e2639. doi: 10.1371/journal.pntd.0002639.

17.

Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays.

Geluk A, van der Ploeg-van Schip JJ, van Meijgaarden KE, Commandeur S, Drijfhout JW, Benckhuijsen WE, Franken KL, Naafs B, Ottenhoff TH.

Clin Vaccine Immunol. 2010 Jun;17(6):993-1004. doi: 10.1128/CVI.00046-10.

18.
19.

Comparison of two mice strains, A/J and C57BL/6, in caspase-1 activity and IL-1beta secretion of macrophage to Mycobacterium leprae infection.

Kang TJ, Lee GS, Kim SK, Jin SH, Chae GT.

Mediators Inflamm. 2010;2010:708713. doi: 10.1155/2010/708713.

Items per page

Supplemental Content

Support Center